Impella

Type: Product
Name: Impella
First reported Jul 22 2014 - Updated Jul 22 2014 - 1 reports

ABIOMED Makes a Move: Up 2.8%...

One of today's stocks on the move is ABIOMED (NASDAQ:ABMD), up 2.8% to $25.99. The Dow Jones Industrial Average is now trading 0.3% higher to 17,110 and the S&P is trading 0.5% higher to 1,985.Abiomed, Inc. provides medical devices in circulatory support ... [Published Financial News Network online - Jul 22 2014]
First reported Jul 16 2014 - Updated Jul 16 2014 - 1 reports

ARGEN X : Forbion Announces Closing of Initial Public Offering of Portfolio Company arGEN-X

By a News Reporter-Staff News Editor at Biotech Week -- Forbion Capital Partners , the leading Dutch Venture Capital firm investing in world-class healthcare technologies, is proud to announce that its portfolio company arGEN-X N.V. (arGEN-X or the company), ... [Published 4 Traders - Jul 16 2014]
First reported Jul 09 2014 - Updated Jul 10 2014 - 2 reports

Forbion Capital Partners’ arGEN-X completes IPO

Clinical-stage biopharmaceutical company arGEN-X has completed its IPO. arGEN-X is a Forbion Capital Partners ‘ portfolio company. PRESS RELEASE Forbion Capital Partners, the leading Dutch Venture Capital firm investing in world-class healthcare ... [Published PE Hub Blog - Jul 09 2014]
First reported Jul 07 2014 - Updated Jul 07 2014 - 1 reports

Abiomed announces acquisition of ECP

Abiomed has announced the acquisition of Germany-based medical device company ECP Entwicklungsgesellschaft mbH to broaden and strengthen existing intellectual property and product platform.Currently, ECP is developing a percutaneous, expandable catheter ... [Published Medical Devices Business Review - Jul 07 2014]
First reported Jul 01 2014 - Updated Jul 02 2014 - 5 reports

ABIOMED Acquires Germany's Medical Device Maker

ABIOMED Inc. ( ABMD ) revealed that it has acquired Berlin, Germany-based medical device maker Entwicklungsgesellschaft mbH or ECP. The acquisition is in line with its strategy to provide percutaneous hemodynamic support for minimally invasive procedures ... [Published Yahoo! Finance - Jul 02 2014]
First reported Jun 26 2014 - Updated Jun 26 2014 - 1 reports

US Federal Business Opportunity: Department of Veterans Affairs: J--Impella AIC Equipment PM Period of Performance: 7/1/14-6/30/15

Agency: Department of Veterans AffairsOffice: Seattle VAMC Location: Department of Veterans Affairs Puget Sound Health Care SystemDate you need to respond by:Solicitation Number: VA26014AP3714 Naics code: 334510 Computer and Electronic Product Manuf ... [Published ITbriefing - Jun 26 2014]
First reported Jun 26 2014 - Updated Jun 26 2014 - 1 reports

Oxford Bioscience-backed Mitralign Raises $8 Million

According to an SEC filing, Mitralign Inc. has raised $8 million via sale of shares to 12 investors.The company, according to Crunchbase, has previously received $42 million from two rounds, including $35 million in Series D funding and $7 million in ... [Published Citybizlist - Jun 26 2014]
First reported Jun 23 2014 - Updated Jun 23 2014 - 1 reports

Massapequa Schoolteacher Saved from Rare Heart Virus at St. Francis Hospital

“Please don’t let me die,” said Enzamaria Grimaudo, of Massapequa, before going into cardiac arrest. The 30-year-old schoolteacher clutched at a nurse as she began to turn blue. “Don’t worry,” the nurse said. “We won’t.”For the next four hours, doctors ... [Published Massapequa Patch - Jun 23 2014]
First reported Feb 20 2014 - Updated Feb 20 2014 - 1 reports

Forbion Announces Closing of Public Offering of Portfolio Company Argos Therapeutics

Forbion portfolio company developing novel cancer immunotherapy , based on Nobel Prize-winning scienceNaarden, The Netherlands – February 20 2014 – Forbion Capital Partners, the leading Dutch VC firm investing in world-class healthcare technologies, ... [Published BioPortfolio - Feb 20 2014]
First reported Feb 13 2014 - Updated Feb 13 2014 - 1 reports

Forbion Capital-backed uniQure completes IPO

Forbion Capital Partners -backed uniQure , which develops gene therapy products, has completed an initial public offering at a price of $17 per share on the NASDAQ . Jefferies and Leerink Partners acted as joint book-running managers and Piper ... [Published PE Hub Blog - Feb 13 2014]

Quotes

Christina Takke, Board Member of arGEN-X and Partner at Forbion Capital Partners , added: "Forbion has actively supported the company since co-leading its Series A funding round in 2009. We were closely involved in its evolution from a research-driven private venture to a product-focused, clinical-stage public company. It's exciting to see that the combination of excellent management, powerful technology and outstanding development expertise can lead to such value creation in a short time frame, when coupled with intelligent financing."
"As the established leader in percutaneous heart pumps with deep relationships in cardiology, existing regulatory approvals, extensive IP, a solid pipeline and strong cash balance, this acquisition further strengthens our position as the long-term innovator and leader in the field of temporary ventricular assist devices" chairman, president & CEO Michael Minogue said in prepared remarks
NEXT ARTICLE More From BioPortfolio on "Forbion Announces Closing of Public Offering of Portfolio Company, Argos Therapeutics"

More Content

All (20) | News (13) | Reports (0) | Blogs (2) | Audio/Video (0) | Fact Sheets (0) | Press Releases (5)
sort by: Date | Relevance
ABIOMED Makes a Move: Up 2.8%... [Published Financial News Network online - Jul 22 2014]
ARGEN X : Forbion Announces Closing of Initial ... [Published 4 Traders - Jul 16 2014]
Forbion Capital Partners’ arGEN-X completes IPO [Published PE Hub Blog - Jul 09 2014]
Forbion Announces Closing of Initial Public Off... [Published CNBC - Jul 09 2014]
Abiomed announces acquisition of ECP [Published Medical Devices Business Review - Jul 07 2014]
ABIOMED Acquires Germany's Medical Device Maker [Published Yahoo! Finance - Jul 02 2014]
Danvers heart device firm Abiomed acquires two ... [Published Boston Business Journal - Jul 02 2014]
Abiomed acquires German heart pump maker ECP [Published MassDevice - Jul 02 2014]
Abiomed Inc announces acquisition of ECP to bro... [Published Reuters - Jul 01 2014]
Abiomed Buys Germany-based ECP [Published RTTNews.com - Jul 01 2014]
US Federal Business Opportunity: Department of ... [Published ITbriefing - Jun 26 2014]
Oxford Bioscience-backed Mitralign Raises $8 Mi... [Published Citybizlist - Jun 26 2014]
Massapequa Schoolteacher Saved from Rare Heart ... [Published Massapequa Patch - Jun 23 2014]
Abiomed Surpasses 20,000 Impella Patients in th... [Published GlobeNewswire: Advertising News - Jun 03 2014]
Abiomed Receives Continuous Access Protocol (CA... [Published GlobeNewswire: Advertising News - May 21 2014]
Abiomed's Impella(R) Technology Showcased at Eu... [Published GlobeNewswire: Acquisitions News - May 19 2014]
Impella Maintains Existing Diagnosis Related Gr... [Published GlobeNewswire: Acquisitions News - Mar 21 2014]
Abiomed Completes Patient Enrollment in RECOVER... [Published GlobeNewswire: Acquisitions News - Mar 20 2014]
Forbion Announces Closing of Public Offering of... [Published BioPortfolio - Feb 20 2014]
Forbion Capital-backed uniQure completes IPO [Published PE Hub Blog - Feb 13 2014]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Forbion Capital Partners’ arGEN-X completes IPO [Published PE Hub Blog - Jul 09 2014]
Clinical-stage biopharmaceutical company arGEN-X has completed its IPO. arGEN-X is a Forbion Capital Partners ‘ portfolio company. PRESS RELEASE Forbion Capital Partners, the leading Dutch Venture Capital firm investing in world-class healthcare ...
Forbion Capital-backed uniQure completes IPO [Published PE Hub Blog - Feb 13 2014]
Forbion Capital Partners -backed uniQure , which develops gene therapy products, has completed an initial public offering at a price of $17 per share on the NASDAQ . Jefferies and Leerink Partners acted as joint book-running managers and Piper ...
1

Press Releases

sort by: Date | Relevance
Abiomed Surpasses 20,000 Impella Patients in th... [Published GlobeNewswire: Advertising News - Jun 03 2014]
Abiomed Receives Continuous Access Protocol (CA... [Published GlobeNewswire: Advertising News - May 21 2014]
Abiomed's Impella(R) Technology Showcased at Eu... [Published GlobeNewswire: Acquisitions News - May 19 2014]
Impella Maintains Existing Diagnosis Related Gr... [Published GlobeNewswire: Acquisitions News - Mar 21 2014]
Abiomed Completes Patient Enrollment in RECOVER... [Published GlobeNewswire: Acquisitions News - Mar 20 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.